# Hydrocortisone Use During Peri-operation for Pituitary Adenomas

> **NCT04621565** · NA · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 436 (estimated)

## Conditions studied

- Pituitary Adenoma
- Adrenal Insufficiency
- Surgery

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT04621565
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 436 (ESTIMATED)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04621565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04621565, "Hydrocortisone Use During Peri-operation for Pituitary Adenomas". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04621565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*